difference between semaglutide and phentermine vs for Weight Loss Phentermine vs. Semaglutide: Which Is

Semaglutide, Ozempic, Mounjaro and Wegovy all have the potential side effect of causing feelings of nausea

In 2025, Novo Nordisks semaglutide awaits several first-time FDA decisions: 3Q 2025 the first GLP-1 (Wegovy) for metabolic dysfunction-associated steatohepatitis (MASH) 4Q 2025 the first oral GLP-1 ( oral formulation of Wegovy 25 mg ) for weight loss and weight loss plus secondary CV risk reduction 4Q 2025 Wegovy for heart failure with preserved ejection fraction and obesity October 2025 new indication for oral Rybelsus for secondary CV risk reduction 2025 Ozempic for T2DM and peripheral artery disease (PAD) Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics (Prime) talented team of clinical experts actively monitors this emerging landscape

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established

Non-steroidal anti-inflammatory drugs (NSAIDs), among the most widely used over-the-counter pain medications, such as ibuprofen, naproxen, and aspirin, are commonly used as first-line pain relievers